CVLB · Conversion Labs, Inc
-
-
| ISIN | None |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| CurrencyCode | USD |
| Exchange | NASDAQ |
| Market Cap | 703M |
|---|---|
| Dividend Yield | 0.0% |
| Target Price | 37.5 |
| PE Ratio | None |
| Beta | 1.15 |
ABOUT
Conversion Labs, Inc
Conversion Labs, Inc. operates as a telemedicine company with a portfolio of online direct-to-consumer brands. The company combines virtual medical treatment with prescription medications and over-the-counter products. Its network of physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the U.S. Its brand portfolio comprises of brands targeting market segments, such as hair loss, immune health, men's health, and disaster preparedness. The company was formerly known as Immudyne, Inc. and changed its name to Conversion Labs, Inc. in June 2018. Conversion Labs, Inc. was founded in 1994 and is based in New York, New York.
Learn More